Point72 Hong Kong’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$328K Buy
+11,839
New +$328K 0.02% 271
2022
Q4
Sell
-350
Closed -$4K 664
2022
Q3
$4K Buy
350
+290
+483% +$3.31K ﹤0.01% 1281
2022
Q2
$1K Buy
60
+45
+300% +$750 ﹤0.01% 1368
2022
Q1
$0 Sell
15
-1,674
-99% ﹤0.01% 1587
2021
Q4
$20K Sell
1,689
-124
-7% -$1.47K ﹤0.01% 997
2021
Q3
$21K Buy
+1,813
New +$21K ﹤0.01% 1092
2020
Q3
Sell
-2,680
Closed -$68K 1358
2020
Q2
$68K Buy
2,680
+2,563
+2,191% +$65K 0.01% 691
2020
Q1
$2K Sell
117
-180
-61% -$3.08K ﹤0.01% 851
2019
Q4
$3K Sell
297
-55
-16% -$556 ﹤0.01% 1056
2019
Q3
$3K Sell
352
-631
-64% -$5.38K ﹤0.01% 842
2019
Q2
$13K Buy
+983
New +$13K ﹤0.01% 836
2018
Q3
Sell
-262
Closed -$5K 1040
2018
Q2
$5K Buy
+262
New +$5K ﹤0.01% 703